RNS Number : 1363M
Proximagen Neuroscience Plc
18 May 2010
PROXIMAGEN GROUP PLC
("Proximagen" or "the Company")
Results of Annual General Meeting and General Meeting
Change of company name
Change of registered office
London, UK, 18 May 2010 - Proximagen Group plc (AIM: PRX), the biotechnology company focused on diseases of the central nervous system, announces that, at its Annual General Meeting which was held earlier today, all resolutions put to shareholders were duly passed.
The Company also announces, following the passing of the Special Resolution at the Company's General Meeting also held earlier today, that the Company has changed its name from Proximagen Neuroscience plc to Proximagen Group plc. The Company's Stock Code remains unchanged: PRX.
The Company also announces that it has changed its registered office to 3rd Floor, 91-93 Farringdon Road, London EC1M 3LN, with immediate effect.
Enquiries
|
Proximagen Group plc
|
Phone: +44 (0)20 7848 6938
|
|
James Hunter, Finance Director
|
|
|
|
|
|
Evolution Securities Limited (NOMAD)
|
Phone: +44 (0)20 7071 4300
|
|
Stuart Andrews, Bobbie Hilliam, Tim Redfern
|
|
|
|
|
|
Pelham Bell Pottinger
|
Phone: +44 (0)20 7861 3800
|
|
Dan de Belder, Zoë Pocock
|
|
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGSFWFDAFSSEII